Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Elsunersen by Praxis Precision Medicines for Epileptic Encephalopathy: Likelihood of Approval
Elsunersen is under clinical development by Praxis Precision Medicines and currently in Phase III for Epileptic Encephalopathy. According to GlobalData,...